SRPT — SAREPTA THERAPEUTICS INC

Ownership history in Point72 (DIFC) Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in SAREPTA THERAPEUTICS INC (SRPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.09% (2024 Q1)
Avg. % of fund
0.05%
First filed
2024 Q1
Last filed
2025 Q2
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 853 -21,221 -96.1% 0.00% $15K $17.10
2024 Q1 INITIATED 22,074 — — 0.09% $2.9M —
% of Fund (quarterly)    SRPT price (monthly, adj. close)

Other funds also holding SRPT

As of 2025 Q4 — sorted by position size

Lion Point Capital, LP 3Y 7Y 3.17% 683 Capital Management, LLC 3Y 7Y 0.76% Erste Asset Management GmbH 0.49% Mirador Capital Partners LP 3Y 7Y 0.41% Voleon Capital Management LP 3Y 7Y 0.41% Neo Ivy Capital Management 3Y 7Y 0.4% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.37% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.33% HIGHBRIDGE CAPITAL MANAGEMENT LLC 3Y 7Y 0.27% VIRTUS ADVISERS, LLC 3Y 7Y 0.26%
← Back to Point72 (DIFC) Ltd Holdings